| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.733 | 9.849 | 9.655 | 10.601 | 22.096 | 30.989 |
| Total Income - EUR | - | - | - | - | 1.733 | 9.849 | 9.655 | 10.601 | 22.096 | 31.505 |
| Total Expenses - EUR | - | - | - | - | 429 | 55 | 1.726 | 4.398 | 8.359 | 13.545 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.304 | 9.793 | 7.929 | 6.203 | 13.738 | 17.959 |
| Net Profit/Loss - EUR | - | - | - | - | 1.252 | 9.519 | 7.639 | 5.885 | 11.618 | 14.195 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Microbiologica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 1.015 | 13.173 |
| Current Assets | - | - | - | - | 1.979 | 11.497 | 18.887 | 24.418 | 38.202 | 31.719 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 1.654 | 3.032 | 3.593 | 2.426 | 8.443 |
| Cash | - | - | - | - | 1.979 | 9.843 | 15.855 | 20.825 | 35.776 | 23.275 |
| Shareholders Funds | - | - | - | - | 1.295 | 10.789 | 18.189 | 5.926 | 17.525 | 31.622 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 684 | 708 | 698 | 18.493 | 21.692 | 13.270 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Microbiologica S.r.l.